Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Parkinson's disease (PD) is a prevalent neurodegenerative disorder primarily affecting motor function.
• Dysregulation of microRNAs (miRNAs), small non-coding RNAs, is implicated in PD neurodegeneration.
• Identifying specific miRNAs can elucidate disease mechanisms and aid diagnosis.

Purpose of the Study:

• To investigate the differential expression of inflammation-related miRNAs in the serum of PD patients and healthy controls.
• To assess the diagnostic potential of identified miRNAs in distinguishing PD subtypes and controls.
• To explore the role of specific miRNAs in the pathophysiology of idiopathic PD (iPD) and leucine-rich repeat kinase 2 (LRRK2) gene-mutated PD (LRRK2-PD).

Main Methods:

• Serum samples from two independent cohorts of iPD patients and healthy controls were analyzed.
• miRNA expression profiling was performed using Taqman quantitative reverse transcription polymerase chain reaction (qRT-PCR).
• Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic performance of miRNAs.

Main Results:

• miR-146a, miR-335-3p, and miR-335-5p were found to be downregulated in both iPD and LRRK2-PD patients compared to controls across both cohorts.
• miR-155 was significantly upregulated in LRRK2-PD patients relative to iPD patients, with an area under the ROC curve (AUC) of 0.80.
• These findings indicate distinct miRNA expression patterns associated with different PD etiologies.

Conclusions:

• A panel of inflammation-related miRNAs, including miR-146a, miR-335-3p, miR-335-5p, and miR-155, are differentially expressed in PD.
• These miRNAs highlight crucial pathophysiological processes in PD.
• The identified miRNAs show potential as biomarkers for improving the diagnosis of Parkinson's disease.